Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luciano Adorini

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
International Immunopharmacology|August 22, 2002
Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseasesLuciano Adorini
Journal of the Neurological Sciences|July 21, 2004
Immunotherapeutic approaches in multiple sclerosisLuciano Adorini
Trends in Biotechnology|October 20, 2004
Antigen-based immunointervention in human autoimmune diseasesLuciano Adorini
Annals of the New York Academy of Sciences|May 3, 2003
Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetesLuciano Adorini
Current Opinion in Investigational Drugs (London, England : 2000)|November 15, 2002
1,25-Dihydroxyvitamin D3 analogs as potential therapies in transplantationLuciano Adorini
Cellular Immunology|June 7, 2005
Intervention in autoimmunity: the potential of vitamin D receptor agonistsLuciano Adorini
International Archives of Allergy and Immunology|June 25, 2021
Immunotherapy of Autoimmune DiseaseLuciano Adorini
Trends in Molecular Medicine|April 3, 2002
The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agentsChantal Mathieu, Luciano Adorini
Journal of Hepatology|August 10, 2023
FXR agonists in NASH treatmentLuciano Adorini, Michael Trauner
Human Immunology|May 1, 2009
Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonistsLuciano Adorini, Giuseppe Penna
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
International Immunopharmacology|August 22, 2002
Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseasesLuciano Adorini
Journal of the Neurological Sciences|July 21, 2004
Immunotherapeutic approaches in multiple sclerosisLuciano Adorini
Trends in Biotechnology|October 20, 2004
Antigen-based immunointervention in human autoimmune diseasesLuciano Adorini
Annals of the New York Academy of Sciences|May 3, 2003
Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetesLuciano Adorini
Current Opinion in Investigational Drugs (London, England : 2000)|November 15, 2002
1,25-Dihydroxyvitamin D3 analogs as potential therapies in transplantationLuciano Adorini
Cellular Immunology|June 7, 2005
Intervention in autoimmunity: the potential of vitamin D receptor agonistsLuciano Adorini
International Archives of Allergy and Immunology|June 25, 2021
Immunotherapy of Autoimmune DiseaseLuciano Adorini
Trends in Molecular Medicine|April 3, 2002
The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agentsChantal Mathieu, Luciano Adorini
Journal of Hepatology|August 10, 2023
FXR agonists in NASH treatmentLuciano Adorini, Michael Trauner
Human Immunology|May 1, 2009
Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonistsLuciano Adorini, Giuseppe Penna
Pageof 13